Medibank has confirmed its core operations remain insulated from international financial market turbulence due to their entirely domestic footprint.
However, the insurer does maintain a $240 million equities portfolio with both domestic and offshore holdings as of Dec. 31, 2024.
The company stated that these holdings have yielded positive returns during the first four months of 2025.
The investment portfolio’s sensitivity to the RBA cash rate remains a consideration. A change of 25 basis points in the official rate equates to an approximate $7 million annual fluctuation in investment income.
Medibank acknowledged that further reductions in the cash rate could help alleviate financial strain on households, thereby potentially boosting access to healthcare and customer retention.
Medibank has implemented several measures to ease the financial burden on its members amid ongoing cost-of-living concerns.
A $160 million customer giveback, set for distribution to members with active policies on June 30, was announced in February. This will bring the insurer’s total pandemic-era support to $1.62 billion.
Other customer initiatives include rolling over unused benefits for ahm extras – excluding optical and orthodontic benefits – for services such as dental and physiotherapy.
A separate commitment includes a $50 million mental health investment over five years, aimed at increasing access to care options and expanding preventive services.
In terms of pricing, Medibank applied a 3.99% average increase to health insurance premiums from April 1.
Industry data from the Australian Prudential Regulation Authority (APRA) released in early 2025 showed 2.33% growth in resident policyholders for the year ending Dec. 31, 2024.
Medibank noted sustained growth in first-time policyholders and an increase in hospital cover uptake among Australians under 30 – the most significant annual increase since 2012.
The insurer attributed its membership growth to focused strategies around specific customer segments, including families, corporate clients, and new entrants.
During the March quarter, the insurer reported growth in its Medibank-branded products and increased conversions from non-resident to resident coverage.
The company said it would continue to develop its position in the non-resident market, with an emphasis on the international worker and visitor categories through FY26.
Claim trends observed earlier in FY25 have continued, with lower than anticipated extras claims and reduced risk equalisation payments. Medibank attributed this to favourable demographics among claimants and controlled growth initiatives.
Hospital claims have also remained below forecast levels since December, albeit with less variance than earlier in the financial year.
The insurer confirmed that private hospital indexation remains in line with expectations.
Through strategic provider agreements, Medibank aims to moderate rising healthcare costs while preserving access.
Current projections for FY25 place policy unit claim growth in the range of 2.4% to 2.6%.
Medibank is continuing its long-term strategy to diversify from a traditional insurer into a broader health services provider.
As of early 2025, nearly half of Medibank’s customer base engages with its wellness and preventative care programs. Its “Live Better” initiative has surpassed 900,000 members.
The digital health service under the Overseas Student Health Cover app has recorded more than double the number of interactions compared to the prior year.
In primary care, Myhealth – Medibank’s medical centre network – reported increased consultations and improved revenue mix during the financial year to date. Medibank noted continued growth potential due to policy momentum around strengthening primary care.
Medibank is also expanding its footprint through Amplar Health, with new aged care partnerships and post-hospital transition services. New facilities such as Nundah Private Hospital and Adeney Private Hospital reflect a shift toward integrated models of care, including virtual nursing and no-gap billing structures.
Looking ahead, Medibank said it intends to maintain momentum in customer volume growth and expand access to its healthcare offerings across payer categories.
It reaffirmed a target of 15% annual organic profit growth between FY24 and FY26 within its health services division, alongside contributions from Myhealth.
Planned capital deployment for mergers and acquisitions remains between $150 million and $250 million over the same period, with an emphasis on strengthening its healthcare delivery network.
